Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "defective product" wg kryterium: Temat


Wyświetlanie 1-2 z 2
Tytuł:
Minimizing Product Defects Based on Labor Performance using Linear Regression and Six Sigma Approach
Autorzy:
Nurprihatin, Filscha
Ayu, Yayang Nadistya
Rembulan, Glisina Dwinoor
Andry, Johanes Fernandes
Lestari, Tika Endah
Powiązania:
https://bibliotekanauki.pl/articles/24200495.pdf
Data publikacji:
2023
Wydawca:
Polska Akademia Nauk. Czasopisma i Monografie PAN
Tematy:
labor performance
overall labor effectiveness
defective product
six sigma
DMAIC approach
Opis:
The objective of this research is to minimize product defects based on labor performance and prove the hypothesis on how labor performance affects the quality of a product through a scientific calculation using Overall Labor Effectiveness (OLE). The primary data is obtained by interviewing the supervisor and labor directly. For secondary data is obtained from the company, such as labor working time, machine scheduled downtime, total production, and defective products. The approach to extract the data is using OLE and the continued regression method. Furthermore, it proceeds to Six Sigma using the DMAIC approach since the results show a significant correlation. The result from Failure Mode and Effects Analysis (FMEA) shows four of six potential failures caused by product defects are coming from labor. To prevent failure mode, it is recommended to have the regular machine checked by labor, check the temperature of the machine, and provide Standard Operating Procedures.
Źródło:
Management and Production Engineering Review; 2023, 14, 2; 88--98
2080-8208
2082-1344
Pojawia się w:
Management and Production Engineering Review
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
CAUSAL EFFECT RELATIONSHIP IN MEDICAL CASES. AN OLD PROBLEM IN A NEW SCENARIO. COMMENTARY TO CJEU JUDGMENT (SECOND CHAMBER) OF 21 JUNE 2017, N.W. & OTHERS V. SANOFI PASTEUR MSD & OTHERS, CASE C-621/15, EU:C:2017:484 APPROBATIVE GLOSS
Autorzy:
Wnukiewicz-Kozłowska, Agata
Drozdowska, Urszula Dorota
Powiązania:
https://bibliotekanauki.pl/articles/1597407.pdf
Data publikacji:
2021-08-21
Wydawca:
Katolicki Uniwersytet Lubelski Jana Pawła II
Tematy:
uncertain causation, standard of proof, vaccine, damage, defective medical product
Opis:
This commentary evaluates the problem in assessing the role of a causal connection between damage and the use of a defective medical product, specifically a vaccine. The judgment of the Court of Justice of the European Union (CJEU) in the Sanofi Pasteur Case, which allowed the possibility of recognizing damage claims, even in cases where the prevailing scientific theory claims that there is no scientific evidence of a causal link between a vaccination and the disease, became a base for consideration. Consequently, procedural solutions (such as the standard of proof required, the admissibility of prima facie evidence reasoning and other solutions in cases of an uncertain causation) remain to be decided by national law. The authors assessed two legal systems: the French and Polish legal systems in the context of how to resolve these dilemmas and to describe the impact of the above-mentioned judgment on the case-law of French and Polish courts as regards the application of Directive 85/374/EEC. As a result, they concluded that the most important interpretative motive has become the individual interest of the vaccination’s victim as a consumer of medical services. It seems to be in accordance with Directive 85/374/EEC, which is motivated by the necessity of approximation of the laws of the Member States concerning the liability of the producer for damage caused by the defectiveness of his products. However, since the existing divergences may distort competition and affect the movement of goods within the common market and entail a differing degree of protection of the consumer against damage caused by a defective product to his health or property, in countries belonging to the European Union, the authors wonder how the commented judgment will affect the further development of consumers protection against defective vaccines.
Źródło:
Review of European and Comparative Law; 2021, 46, 3; 263-290
2545-384X
Pojawia się w:
Review of European and Comparative Law
Dostawca treści:
Biblioteka Nauki
Artykuł
    Wyświetlanie 1-2 z 2

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies